GovChime
AWARDBPA CALLOther than small business

BPA call 75F40120F19131BRILLIENT CORPORATION

Overview

Award facts

Net obligations
$2.19M
$2,187,302of $2.19M potential value
Outlays (paid to date)
$1.77M
$1.77M paid of $2.19M obligated$1,765,563
Period of performance
Jul 14, 2020 to Aug 31, 2024
Ended
Modifications
9
Latest action Mar 28, 2025
Contract type
BPA call
PIID 75F40120F19131

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

TIME AND MATERIALS AWARD PROVIDE PROJECT MANAGER SUPPORT SERVICES FOR THE GENERIC DRUG PROGRAM; SERVICES TO PROVIDE RESEARCH AND REGULATORY HEALTH PROJECT MANAGEMENT SUPPORT FOR THE GENERIC DRUG USER FEE AMENDMENTS (GDUFA)- FUNDED REGULATORY SCIENCE

Dates and value

Award date
Signed on Jul 14, 2020
Potential end of performance
Aug 30, 2024
Current value
$2,187,302Base and exercised options
Potential value (if all options are exercised)
$2,187,302
Parent contract vehicle
HHSF223201810005B (BPA, single award) — 301 orders recorded under it

Obligations by fiscal year of action

  • FY2025: -$171,313 (de-obligation)
  • FY2024: $313,595
  • FY2023: $307,308
  • FY2022: $616,724
  • FY2021: $750,272
  • FY2020: $370,716

Total across 6 fiscal years: $2,187,302

Net de-obligation in that fiscal year (obligations withdrawn).

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Mar 28, 2025. View on USAspending · Recipient on SAM.gov

Recipient

LocationRESTON, VA
UEIMMAVC7UGLJ78
CAGE code463W1
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyBRILLIENT CORPORATION

Business types and certifications

Minority-ownedSelf-certified small disadvantaged businessFor-profit organizationSubchapter S corporationCorporation (not tax-exempt)

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Funded by
  1. Department of Health and Human Services
  2. Food And Drug Administration
  3. FDA OFFICE OF ACQ GRANT SVCS
Funded from
Fda user fees (non general fund)Program activities075-0600Federal accounts (agency financial reports)

Place of performance

Place of performance
Rockville, Montgomery County, Maryland 20857-0001
Congressional district (place of performance)
MD-08As reported at the time of the action

Classification and competition

Classification

Competition

Extent competed
Full and open competitionA
Solicitation procedures
Subject to multiple award fair opportunityMAFO
Set-aside
Not reported
Contract pricing
Time and materialsY

Contract details

Major program
Professional and technial services blanket purchase agreement
Service Contract Act labor standards
Yes
Commercial procedures
Commercial products/servicesA
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Performance-based service acquisition
Yes - service where PBA is used.Y

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
Jul 14, 2020Base obligation at award: $370,716
Latest action
Mar 28, 2025 — CloseoutModification P00009; obligation change -$171,313; administrative: no change in scope or value
Latest substantive action
May 1, 2024 — New work added (outside scope)Modification P00008; obligation change +$163,460
Latest funding action
Jan 16, 2024 — Funding onlyModification P00007; obligation change +$150,135; funding only: changes obligations, not scope
Actions by type
  • Base award1
  • Option exercised3
  • Funding only2
  • New work added (outside scope)1
  • Supplemental agreement (within scope)1
  • Closeout1
  • Other administrative action1
10 actions recorded, Jul 14, 2020 to Mar 28, 2025; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No
Latest action: change in base and exercised options
-$171,313
Latest action: change in base and all options
-$171,313

Socio-economic and policy

Inherently governmental functions
Closely associatedCL
Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No

Place and origin

Domestic or foreign entity
U.S. owned businessA
Country of product or service origin
United statesUSA
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
BPA callA
Parent vehicle type
BPAE
Parent vehicle: multiple or single award
Single awardS
Parent vehicle agency
Food And Drug Administration7524
Awarding agency code
7500
Awarding sub-tier code
7524
Contracting office code
75F401
Transactions recorded under this award key
10

Funding

Funding agency code
7500
Funding sub-tier code
7524
Funding office code
75F401
Treasury accounts
  • 075-X-0600-000
Object classes
  • 25.1: Advisory and assistance services
  • 25.2: Other services from non-Federal sources
  • 25.5: Research and development contracts
Disaster or emergency funding (DEFC)
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression